High-throughput dynamic reagent delivery system
The present invention generally relates to a controlled fluidic device to develop spatially complex environments to enhance the rate of evolution in cell populations. The method further provides an enhanced understanding in the emergence, for example, drug resistance during cancer chemotherapy.
1. A microfluidic device component for establishing a gradient, comprising:
a chamber defining an interior space; and
two or more inlet ports that deliver two or more different fluids to the interior space of the chamber and two or more outlet ports, wherein the two or more inlet ports comprise at least a first inlet port and a second inlet port, the two or more outlet ports comprise at least a first outlet port and a second outlet port, the first inlet port and the first outlet port are located at a first vertex of the chamber and the second inlet port and second outlet port are located at a second opposing vertex of the chamber so that the flow of the two or more fluids into the interior space results in formation of a gradient across the interior space; wherein the interior space comprises a plurality of three or more regularly spaced columns throughout the interior space and a plurality of three or more wells interspersed between the plurality of columns and wherein each well is in fluid communication with adjacent wells.
2. The microfluidic device component of claim 1 , wherein the chamber is polygonal in shape.
3. The microfluidic device component of claim 2 , wherein the chamber is square or hexagonal in shape.
4. The microfluidic device component of claim 1 , wherein the chamber is 1.4 mm to 1.7 mm wide.
5. The microfluidic device component of claim 1 , wherein the two or more inlet ports and the two or more outlet ports are connected via peripheral channels running along an exterior edge of the chamber, and wherein the peripheral channels comprise a plurality of openings along an interior wall of the chamber to allow fluid communication between the peripheral channels and the interior space.
6. The microfluidic device component of claim 5 , wherein the peripheral flow channels have a depth of approximately 5 μm to 500 μm.
7. The microfluidic device component of claim 1 , wherein the first inlet port and first outlet port are separated by an angle of 130 to 220 degrees and the second inlet port and second outlet port are separated by an angle of 130 to 220 degrees.
8. A method for screening one or more cell types for one or more biological functions, comprising:
introducing one or more cell types into the chamber of the microfluidic device component of claim 1 ;
flowing two or more solutions into the chamber to establish a gradient within the interior space of the chamber; and
measuring a cellular response of the one or more cell types across the gradient.
9. The method of claim 8 , wherein measuring the cellular response comprises detecting changes in cell membrane morphologies, changes in nuclear or organelle morphologies, changes in cytoskeletal arrangement, changes in vesicle trafficking, changes in cell motility, cell inhibition, cell death, neoplastic transformation or a combination thereof.
10. The method of claim 8 , wherein measuring the cellular response comprises detecting a label or other detectable signals generated by a reporter element.
11. The method of claim 10 , wherein the label is detectable by photochemical, biochemical, spectroscopic, immunochemical, electrical, optical or chemical detection.
12. The method of claim 11 , where measuring the cellular response comprises light and/or fluorescent microscopy imaging of one or more wells in the interior space of the chamber.
13. The method of claim 8 , wherein the two or more solutions comprise a test solution and a diluent.
14. The method of claim 13 , wherein the test solution comprises one or more therapeutic agents.
15. The method of claim 13 , wherein the cell types are one or more bacterial cells and the test solution comprises one or more antibiotics.
16. The method of claim 8 , further comprising isolating cells from one or more wells in the interior space of the chamber.
17. The method of claim 16 , further comprising sequencing of the isolated cells.
18. A method for identifying an agent that inhibits cellular growth and/or viability of tumorigenic or transformed cells, comprising:
introducing cells from a sample into the chamber of the microfluidic device component of claim 1 ;
culturing the cells in low or no attachment conditions and in the presence of a test agent; and
detecting inhibition of cell growth or viability.
19. The method of claim 18 , wherein the sample is a patient sample.
20. The method of claim 19 , wherein the patient sample is from a tumor.
21. The method of claim 18 , wherein the test agent is a drug or biological therapeutic.